QUINCE THERAPEUTICS INC (QNCX) Stock Analyst Ratings
USA - NASDAQ:QNCX - US22053A1079 - Common Stock
1.65 USD
+0.01 (+0.61%)
ChartMill assigns a Buy % Consensus number of 83% to QNCX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.65. This target is 363.64% above the current price.
QNCX was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about QNCX.
In the previous month the buy percentage consensus was at a similar level.
QNCX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-26 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-12 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-05 | JMP Securities | Initiate | Market Outperform |
| 2025-07-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-24 | Oppenheimer | Initiate | Outperform |
| 2025-02-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-18 | Brookline Capital | Initiate | Buy |
| 2024-11-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-07 | Maxim Group | Initiate | Buy |
| 2024-10-29 | Rodman & Renshaw | Initiate | Buy |
| 2024-10-22 | EF Hutton | Initiate | Buy |